S. sputigena has emerged as a noteworthy oral pathogen, contributing significantly to tooth decay. While it doesn’t independently damage tooth enamel, its synergistic interactions with other bacteria, such as Streptococcus mutans and Porphyromonas gingivalis, exacerbate the overall damage. Antonie van Leeuwenhoek first observed S. sputigena in 1683 through a microscopic examination of his sputum. Carl Flugge described it in 1886 as Spirillum sputigenum. In 1922, Erwin Boskamp revised the name to sputigena, a classification endorsed by the Judicial Commission of the International Systematic Bacteriology Committee in 1958.
Research by Medikeri et al., utilizing 16S rDNA-based PCR analysis, reported the presence of Selenomonas sputigena in 23.3% of healthy subjects, 36.7% of chronic periodontitis non-smokers, and 40% of chronic periodontitis smokers. However, no statistically significant changes were observed in frequency or quantification among these groups. The occurrence and distribution of Selenomonas sputigena in dental plaque may be influenced by various factors such as diet, oral hygiene, host immunity. The bacterium can utilize diverse substrates like glucose, lactate, pyruvate, and amino acids for growth and energy production while also producing hydrogen sulfide, ammonia, and volatile sulfur compounds that contribute to oral malodor.
While information on the endemic or outbreak status of Selenomonas sputigena in humans is lacking, instances of fatal septicemia have been reported in a captive chimpanzee and a captive gorilla. The bacterium has also been isolated from the rumen of cattle and sheep, as well as the feces of pigs and horses, indicating a broader distribution across various host species.
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Selenomonadaceae
Genus: Selenomonas
Species: S. sputigena
Selenomonas sputigena, a gram-negative anaerobic bacterium, exhibits morphological variations, appearing as either short and curved rods resembling a crescent moon or longer, more twisted rods with an S-shaped spiral configuration. The shorter forms measure approximately 1 to 1.5 μm in length and 0.3 μm in thickness, while the elongated forms can reach up to 10 μm in length. The motility of S. sputigena is facilitated by a single flagellum originating from the inner curvature of the cell, inserted into a bullet-shaped structure at the cell membrane.
The bacterium possesses a thin cell wall and an outer membrane containing lipopolysaccharides. Additionally, S. sputigena is equipped with small appendages known as fimbriae, which aid in its adherence to surfaces and interactions with other cells. Notably, S. sputigena demonstrates the capability to form honeycomb-shaped structures, providing encapsulation and protection for other bacteria, such as Streptococcus mutans.
sputigena, an anaerobic gram-negative bacterium, harbors various virulence-associated genes, including adhesins, hemolysins, proteases, and hydrolases. Notably, some of these genes are situated on a transferable plasmid, facilitating horizontal gene transfer among bacteria. Among the identified virulence genes, SELSP_1610 stands out as a diadenylate cyclase, producing cyclic-di-AMP. This secondary messenger plays a pivotal role in regulating cellular functions such as cell wall and potassium homeostasis, adhesion, motility, and flagellar assembly. The plasmid-mediated gene transfer underscores S. sputigena‘s adaptability and potential to modulate its virulence characteristics.
sputigena, recognized as the type species within its genus, shares a 97% 16S ribosomal RNA sequence identity with Selenomonasnoxia, another oral bacterium. The strain ATCC 35185, also known as VPI D 19B-28, CCUG 44933, or DSM 20758, represents the type strain of S. sputigena. Isolated from the subgingival sulcus of a human, this strain provides valuable insights into the species’ characteristics.
Selenomonas sputigena operates as a pathobiont, capable of inducing disease under specific conditions like dysbiosis or host susceptibility. It collaborates with Streptococcus mutans, a recognized pathogen in childhood caries, to construct a distinctive spatial structure & increase biofilm virulence, mainly in tooth decay. In this symbiotic relationship, S. sputigena becomes ensnared in Streptococcal exoglucans, losing motility but actively increasing to form a honeycomb-like multicellular superstructure that encapsulates S. mutans. This dynamic interaction enhances acidogenesis, resulting in increased enamel demineralization and the formation of caries.
sputigena exhibits an adhesive capacity to the tooth surface, participating in the formation of biofilms—a complex bacterial community embedded in a matrix of extracellular polymeric substances (EPS). This biofilm protects against host immune responses and antimicrobial agents while facilitating nutrient exchange and genetic material transfer among bacteria. S. sputigena‘s interactions within the biofilm extend to other bacteria, such as Streptococcus mutans and Tannerella forsythia, both known contributors to tooth decay and periodontal disease. Through these associations, S. sputigena augments the acid production and virulence of these bacteria by supplying them with lactate and other metabolites.
Furthermore, S. sputigena exhibits invasive tendencies, disseminating in host tissues and the bloodstream, leading to systemic infections and complications. The bacterium can enter the bloodstream through various routes, including wounds, dental procedures, or oral lesions, potentially causing sepsis—a life-threatening condition characterized by organ dysfunction or failure. Additionally, S. sputigena can invade the gingival crevice, contributing to periodontitis. It may also disseminate to other body sites, such as the gastrointestinal tract, genitourinary tract, and liver, causing infections and diseases beyond the oral cavity.
Saliva, a dynamic oral fluid, serves as a formidable defense mechanism against S. sputigena and other oral bacteria. It acts both as a physical barrier, washing away bacteria from tooth surfaces and oral mucosa, and as a chemical agent by neutralizing bacterial acids, thereby maintaining a conducive pH environment.
Laden with antimicrobial substances like lysozyme, immunoglobulin A, lactoferrin, and histatins, saliva exerts bactericidal effects, hindering the growth of S. sputigena. Moreover, oral epithelium acts as a robust barrier, preventing bacterial penetration into underlying tissues and expressing receptors like toll-like receptors that trigger an immune response upon detecting S. sputigena antigens.
The oral immune system orchestrates an adaptive response against S. sputigena infection. This specific and memory-based defense involves B cells producing antibodies (IgG and IgM) that bind to bacterial antigens, neutralizing or opsonizing them. This adaptive immune response contributes to long-term protection against S. sputigena and establishes immunological memory.
Simultaneously, the diverse oral microbiota functions as both a commensal and a competitive agent. In a commensal relationship, the oral microbiota benefits the host by modulating the immune system and oral epithelium, creating a protective environment against pathogenic bacteria like S. sputigena.
S. sputigena can contribute to various clinical manifestations, including blood infection (sepsis), gum inflammation (periodontal disease), and tooth decay. In cases of sepsis, the entry of S. sputigena into the bloodstream can lead to widespread inflammation throughout the body, presenting symptoms such as fever, chills, low blood pressure, rapid breathing, and potential organ failure.
In the context of periodontal disease, S. sputigena is implicated in the formation of complex biofilms on tooth surfaces, contributing to chronic gum infections. Clinical signs of periodontal disease include redness, swelling, bleeding, pain, and bad breath. If left untreated, the disease can lead to tooth loss & an increased risk of other health complications.
Moreover, S. sputigena plays a role in tooth decay, contributing to the destruction of the enamel through acid production. Symptoms of tooth decay encompass toothache, sensitivity, discoloration, and the development of cavities. The impact of tooth decay extends beyond aesthetics, affecting the overall function and health of the teeth.
Conventional Polymerase Chain Reaction (PCR): Conventional PCR is a technique employed for the amplification and detection of specific DNA sequences of S. sputigena in subgingival plaque samples. Utilizing species-specific oligonucleotide primers, this method can selectively bind to the target DNA, generating multiple copies for visualization. PCR is known for its simplicity, specificity, and sensitivity, and it is capable of detecting even fewer than 10 S. sputigena cells.
Gene Activity Sequencing: Bacterial gene activity sequencing, utilizing next-generation sequencing (NGS) platforms, offers an in-depth analysis of gene expression in S. sputigena and other bacteria within plaque samples. This advanced technique generates millions of short reads of bacterial RNA transcripts, allowing for mapping to reference genomes. By annotating the reads, it becomes possible to identify genes and pathways involved in bacterial activity, unveiling hidden bacterial species and their functions behind tooth decay.
Microscopic Imaging: Microscopic imaging techniques, including light microscopy, fluorescence microscopy, or electron microscopy, directly observe the morphology and motility of S. sputigena and other bacteria in plaque samples. These imaging methods magnify bacterial cells and structures, providing visual insights into the bacterial characteristics within the oral environment.
Quantitative Polymerase Chain Reaction (qPCR): Quantitative PCR, a molecular technique with high specificity and sensitivity, is employed to detect and quantify S. sputigena DNA in subgingival plaque samples. Using species-specific oligonucleotide primers, qPCR enhances the rapid detection and enumeration of Selenomonas species.
Good oral hygiene practices prevent S. sputigena infections and associated conditions like periodontitis and caries. This includes brushing teeth twice daily, flossing daily, using mouthwash, and having regular dental check-ups. These practices aid in plaque and bacteria removal, preventing the formation of biofilms and cavities.
Smoking is a risk factor that can exacerbate periodontal disease and caries by impairing the immune system and blood flow to the gums. Quitting smoking creates a less favorable environment for anaerobic bacteria like S. sputigena.
Excessive sugar consumption provides a substrate for S. sputigena and other bacteria to produce acid, causing damage to tooth enamel and gums. Limiting sugar intake helps mitigate the risk of S. sputigena infection and its complications.
Using antimicrobial agents as adjunctive therapies to mechanical plaque removal can be effective. These agents, applied locally (toothpaste, gel, rinse, or spray) or systemically (tablets, capsules, or injections), can inhibit bacterial growth. Some effective antimicrobial agents include chlorhexidine, metronidazole, amoxicillin, and tetracycline. Dentist-prescribed and monitored use is essential to prevent adverse effects.
S. sputigena has emerged as a noteworthy oral pathogen, contributing significantly to tooth decay. While it doesn’t independently damage tooth enamel, its synergistic interactions with other bacteria, such as Streptococcus mutans and Porphyromonas gingivalis, exacerbate the overall damage. Antonie van Leeuwenhoek first observed S. sputigena in 1683 through a microscopic examination of his sputum. Carl Flugge described it in 1886 as Spirillum sputigenum. In 1922, Erwin Boskamp revised the name to sputigena, a classification endorsed by the Judicial Commission of the International Systematic Bacteriology Committee in 1958.
Research by Medikeri et al., utilizing 16S rDNA-based PCR analysis, reported the presence of Selenomonas sputigena in 23.3% of healthy subjects, 36.7% of chronic periodontitis non-smokers, and 40% of chronic periodontitis smokers. However, no statistically significant changes were observed in frequency or quantification among these groups. The occurrence and distribution of Selenomonas sputigena in dental plaque may be influenced by various factors such as diet, oral hygiene, host immunity. The bacterium can utilize diverse substrates like glucose, lactate, pyruvate, and amino acids for growth and energy production while also producing hydrogen sulfide, ammonia, and volatile sulfur compounds that contribute to oral malodor.
While information on the endemic or outbreak status of Selenomonas sputigena in humans is lacking, instances of fatal septicemia have been reported in a captive chimpanzee and a captive gorilla. The bacterium has also been isolated from the rumen of cattle and sheep, as well as the feces of pigs and horses, indicating a broader distribution across various host species.
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Selenomonadaceae
Genus: Selenomonas
Species: S. sputigena
Selenomonas sputigena, a gram-negative anaerobic bacterium, exhibits morphological variations, appearing as either short and curved rods resembling a crescent moon or longer, more twisted rods with an S-shaped spiral configuration. The shorter forms measure approximately 1 to 1.5 μm in length and 0.3 μm in thickness, while the elongated forms can reach up to 10 μm in length. The motility of S. sputigena is facilitated by a single flagellum originating from the inner curvature of the cell, inserted into a bullet-shaped structure at the cell membrane.
The bacterium possesses a thin cell wall and an outer membrane containing lipopolysaccharides. Additionally, S. sputigena is equipped with small appendages known as fimbriae, which aid in its adherence to surfaces and interactions with other cells. Notably, S. sputigena demonstrates the capability to form honeycomb-shaped structures, providing encapsulation and protection for other bacteria, such as Streptococcus mutans.
sputigena, an anaerobic gram-negative bacterium, harbors various virulence-associated genes, including adhesins, hemolysins, proteases, and hydrolases. Notably, some of these genes are situated on a transferable plasmid, facilitating horizontal gene transfer among bacteria. Among the identified virulence genes, SELSP_1610 stands out as a diadenylate cyclase, producing cyclic-di-AMP. This secondary messenger plays a pivotal role in regulating cellular functions such as cell wall and potassium homeostasis, adhesion, motility, and flagellar assembly. The plasmid-mediated gene transfer underscores S. sputigena‘s adaptability and potential to modulate its virulence characteristics.
sputigena, recognized as the type species within its genus, shares a 97% 16S ribosomal RNA sequence identity with Selenomonasnoxia, another oral bacterium. The strain ATCC 35185, also known as VPI D 19B-28, CCUG 44933, or DSM 20758, represents the type strain of S. sputigena. Isolated from the subgingival sulcus of a human, this strain provides valuable insights into the species’ characteristics.
Selenomonas sputigena operates as a pathobiont, capable of inducing disease under specific conditions like dysbiosis or host susceptibility. It collaborates with Streptococcus mutans, a recognized pathogen in childhood caries, to construct a distinctive spatial structure & increase biofilm virulence, mainly in tooth decay. In this symbiotic relationship, S. sputigena becomes ensnared in Streptococcal exoglucans, losing motility but actively increasing to form a honeycomb-like multicellular superstructure that encapsulates S. mutans. This dynamic interaction enhances acidogenesis, resulting in increased enamel demineralization and the formation of caries.
sputigena exhibits an adhesive capacity to the tooth surface, participating in the formation of biofilms—a complex bacterial community embedded in a matrix of extracellular polymeric substances (EPS). This biofilm protects against host immune responses and antimicrobial agents while facilitating nutrient exchange and genetic material transfer among bacteria. S. sputigena‘s interactions within the biofilm extend to other bacteria, such as Streptococcus mutans and Tannerella forsythia, both known contributors to tooth decay and periodontal disease. Through these associations, S. sputigena augments the acid production and virulence of these bacteria by supplying them with lactate and other metabolites.
Furthermore, S. sputigena exhibits invasive tendencies, disseminating in host tissues and the bloodstream, leading to systemic infections and complications. The bacterium can enter the bloodstream through various routes, including wounds, dental procedures, or oral lesions, potentially causing sepsis—a life-threatening condition characterized by organ dysfunction or failure. Additionally, S. sputigena can invade the gingival crevice, contributing to periodontitis. It may also disseminate to other body sites, such as the gastrointestinal tract, genitourinary tract, and liver, causing infections and diseases beyond the oral cavity.
Saliva, a dynamic oral fluid, serves as a formidable defense mechanism against S. sputigena and other oral bacteria. It acts both as a physical barrier, washing away bacteria from tooth surfaces and oral mucosa, and as a chemical agent by neutralizing bacterial acids, thereby maintaining a conducive pH environment.
Laden with antimicrobial substances like lysozyme, immunoglobulin A, lactoferrin, and histatins, saliva exerts bactericidal effects, hindering the growth of S. sputigena. Moreover, oral epithelium acts as a robust barrier, preventing bacterial penetration into underlying tissues and expressing receptors like toll-like receptors that trigger an immune response upon detecting S. sputigena antigens.
The oral immune system orchestrates an adaptive response against S. sputigena infection. This specific and memory-based defense involves B cells producing antibodies (IgG and IgM) that bind to bacterial antigens, neutralizing or opsonizing them. This adaptive immune response contributes to long-term protection against S. sputigena and establishes immunological memory.
Simultaneously, the diverse oral microbiota functions as both a commensal and a competitive agent. In a commensal relationship, the oral microbiota benefits the host by modulating the immune system and oral epithelium, creating a protective environment against pathogenic bacteria like S. sputigena.
S. sputigena can contribute to various clinical manifestations, including blood infection (sepsis), gum inflammation (periodontal disease), and tooth decay. In cases of sepsis, the entry of S. sputigena into the bloodstream can lead to widespread inflammation throughout the body, presenting symptoms such as fever, chills, low blood pressure, rapid breathing, and potential organ failure.
In the context of periodontal disease, S. sputigena is implicated in the formation of complex biofilms on tooth surfaces, contributing to chronic gum infections. Clinical signs of periodontal disease include redness, swelling, bleeding, pain, and bad breath. If left untreated, the disease can lead to tooth loss & an increased risk of other health complications.
Moreover, S. sputigena plays a role in tooth decay, contributing to the destruction of the enamel through acid production. Symptoms of tooth decay encompass toothache, sensitivity, discoloration, and the development of cavities. The impact of tooth decay extends beyond aesthetics, affecting the overall function and health of the teeth.
Conventional Polymerase Chain Reaction (PCR): Conventional PCR is a technique employed for the amplification and detection of specific DNA sequences of S. sputigena in subgingival plaque samples. Utilizing species-specific oligonucleotide primers, this method can selectively bind to the target DNA, generating multiple copies for visualization. PCR is known for its simplicity, specificity, and sensitivity, and it is capable of detecting even fewer than 10 S. sputigena cells.
Gene Activity Sequencing: Bacterial gene activity sequencing, utilizing next-generation sequencing (NGS) platforms, offers an in-depth analysis of gene expression in S. sputigena and other bacteria within plaque samples. This advanced technique generates millions of short reads of bacterial RNA transcripts, allowing for mapping to reference genomes. By annotating the reads, it becomes possible to identify genes and pathways involved in bacterial activity, unveiling hidden bacterial species and their functions behind tooth decay.
Microscopic Imaging: Microscopic imaging techniques, including light microscopy, fluorescence microscopy, or electron microscopy, directly observe the morphology and motility of S. sputigena and other bacteria in plaque samples. These imaging methods magnify bacterial cells and structures, providing visual insights into the bacterial characteristics within the oral environment.
Quantitative Polymerase Chain Reaction (qPCR): Quantitative PCR, a molecular technique with high specificity and sensitivity, is employed to detect and quantify S. sputigena DNA in subgingival plaque samples. Using species-specific oligonucleotide primers, qPCR enhances the rapid detection and enumeration of Selenomonas species.
Good oral hygiene practices prevent S. sputigena infections and associated conditions like periodontitis and caries. This includes brushing teeth twice daily, flossing daily, using mouthwash, and having regular dental check-ups. These practices aid in plaque and bacteria removal, preventing the formation of biofilms and cavities.
Smoking is a risk factor that can exacerbate periodontal disease and caries by impairing the immune system and blood flow to the gums. Quitting smoking creates a less favorable environment for anaerobic bacteria like S. sputigena.
Excessive sugar consumption provides a substrate for S. sputigena and other bacteria to produce acid, causing damage to tooth enamel and gums. Limiting sugar intake helps mitigate the risk of S. sputigena infection and its complications.
Using antimicrobial agents as adjunctive therapies to mechanical plaque removal can be effective. These agents, applied locally (toothpaste, gel, rinse, or spray) or systemically (tablets, capsules, or injections), can inhibit bacterial growth. Some effective antimicrobial agents include chlorhexidine, metronidazole, amoxicillin, and tetracycline. Dentist-prescribed and monitored use is essential to prevent adverse effects.
S. sputigena has emerged as a noteworthy oral pathogen, contributing significantly to tooth decay. While it doesn’t independently damage tooth enamel, its synergistic interactions with other bacteria, such as Streptococcus mutans and Porphyromonas gingivalis, exacerbate the overall damage. Antonie van Leeuwenhoek first observed S. sputigena in 1683 through a microscopic examination of his sputum. Carl Flugge described it in 1886 as Spirillum sputigenum. In 1922, Erwin Boskamp revised the name to sputigena, a classification endorsed by the Judicial Commission of the International Systematic Bacteriology Committee in 1958.
Research by Medikeri et al., utilizing 16S rDNA-based PCR analysis, reported the presence of Selenomonas sputigena in 23.3% of healthy subjects, 36.7% of chronic periodontitis non-smokers, and 40% of chronic periodontitis smokers. However, no statistically significant changes were observed in frequency or quantification among these groups. The occurrence and distribution of Selenomonas sputigena in dental plaque may be influenced by various factors such as diet, oral hygiene, host immunity. The bacterium can utilize diverse substrates like glucose, lactate, pyruvate, and amino acids for growth and energy production while also producing hydrogen sulfide, ammonia, and volatile sulfur compounds that contribute to oral malodor.
While information on the endemic or outbreak status of Selenomonas sputigena in humans is lacking, instances of fatal septicemia have been reported in a captive chimpanzee and a captive gorilla. The bacterium has also been isolated from the rumen of cattle and sheep, as well as the feces of pigs and horses, indicating a broader distribution across various host species.
Kingdom: Bacteria
Phylum: Bacillota
Class: Negativicutes
Order: Selenomonadales
Family: Selenomonadaceae
Genus: Selenomonas
Species: S. sputigena
Selenomonas sputigena, a gram-negative anaerobic bacterium, exhibits morphological variations, appearing as either short and curved rods resembling a crescent moon or longer, more twisted rods with an S-shaped spiral configuration. The shorter forms measure approximately 1 to 1.5 μm in length and 0.3 μm in thickness, while the elongated forms can reach up to 10 μm in length. The motility of S. sputigena is facilitated by a single flagellum originating from the inner curvature of the cell, inserted into a bullet-shaped structure at the cell membrane.
The bacterium possesses a thin cell wall and an outer membrane containing lipopolysaccharides. Additionally, S. sputigena is equipped with small appendages known as fimbriae, which aid in its adherence to surfaces and interactions with other cells. Notably, S. sputigena demonstrates the capability to form honeycomb-shaped structures, providing encapsulation and protection for other bacteria, such as Streptococcus mutans.
sputigena, an anaerobic gram-negative bacterium, harbors various virulence-associated genes, including adhesins, hemolysins, proteases, and hydrolases. Notably, some of these genes are situated on a transferable plasmid, facilitating horizontal gene transfer among bacteria. Among the identified virulence genes, SELSP_1610 stands out as a diadenylate cyclase, producing cyclic-di-AMP. This secondary messenger plays a pivotal role in regulating cellular functions such as cell wall and potassium homeostasis, adhesion, motility, and flagellar assembly. The plasmid-mediated gene transfer underscores S. sputigena‘s adaptability and potential to modulate its virulence characteristics.
sputigena, recognized as the type species within its genus, shares a 97% 16S ribosomal RNA sequence identity with Selenomonasnoxia, another oral bacterium. The strain ATCC 35185, also known as VPI D 19B-28, CCUG 44933, or DSM 20758, represents the type strain of S. sputigena. Isolated from the subgingival sulcus of a human, this strain provides valuable insights into the species’ characteristics.
Selenomonas sputigena operates as a pathobiont, capable of inducing disease under specific conditions like dysbiosis or host susceptibility. It collaborates with Streptococcus mutans, a recognized pathogen in childhood caries, to construct a distinctive spatial structure & increase biofilm virulence, mainly in tooth decay. In this symbiotic relationship, S. sputigena becomes ensnared in Streptococcal exoglucans, losing motility but actively increasing to form a honeycomb-like multicellular superstructure that encapsulates S. mutans. This dynamic interaction enhances acidogenesis, resulting in increased enamel demineralization and the formation of caries.
sputigena exhibits an adhesive capacity to the tooth surface, participating in the formation of biofilms—a complex bacterial community embedded in a matrix of extracellular polymeric substances (EPS). This biofilm protects against host immune responses and antimicrobial agents while facilitating nutrient exchange and genetic material transfer among bacteria. S. sputigena‘s interactions within the biofilm extend to other bacteria, such as Streptococcus mutans and Tannerella forsythia, both known contributors to tooth decay and periodontal disease. Through these associations, S. sputigena augments the acid production and virulence of these bacteria by supplying them with lactate and other metabolites.
Furthermore, S. sputigena exhibits invasive tendencies, disseminating in host tissues and the bloodstream, leading to systemic infections and complications. The bacterium can enter the bloodstream through various routes, including wounds, dental procedures, or oral lesions, potentially causing sepsis—a life-threatening condition characterized by organ dysfunction or failure. Additionally, S. sputigena can invade the gingival crevice, contributing to periodontitis. It may also disseminate to other body sites, such as the gastrointestinal tract, genitourinary tract, and liver, causing infections and diseases beyond the oral cavity.
Saliva, a dynamic oral fluid, serves as a formidable defense mechanism against S. sputigena and other oral bacteria. It acts both as a physical barrier, washing away bacteria from tooth surfaces and oral mucosa, and as a chemical agent by neutralizing bacterial acids, thereby maintaining a conducive pH environment.
Laden with antimicrobial substances like lysozyme, immunoglobulin A, lactoferrin, and histatins, saliva exerts bactericidal effects, hindering the growth of S. sputigena. Moreover, oral epithelium acts as a robust barrier, preventing bacterial penetration into underlying tissues and expressing receptors like toll-like receptors that trigger an immune response upon detecting S. sputigena antigens.
The oral immune system orchestrates an adaptive response against S. sputigena infection. This specific and memory-based defense involves B cells producing antibodies (IgG and IgM) that bind to bacterial antigens, neutralizing or opsonizing them. This adaptive immune response contributes to long-term protection against S. sputigena and establishes immunological memory.
Simultaneously, the diverse oral microbiota functions as both a commensal and a competitive agent. In a commensal relationship, the oral microbiota benefits the host by modulating the immune system and oral epithelium, creating a protective environment against pathogenic bacteria like S. sputigena.
S. sputigena can contribute to various clinical manifestations, including blood infection (sepsis), gum inflammation (periodontal disease), and tooth decay. In cases of sepsis, the entry of S. sputigena into the bloodstream can lead to widespread inflammation throughout the body, presenting symptoms such as fever, chills, low blood pressure, rapid breathing, and potential organ failure.
In the context of periodontal disease, S. sputigena is implicated in the formation of complex biofilms on tooth surfaces, contributing to chronic gum infections. Clinical signs of periodontal disease include redness, swelling, bleeding, pain, and bad breath. If left untreated, the disease can lead to tooth loss & an increased risk of other health complications.
Moreover, S. sputigena plays a role in tooth decay, contributing to the destruction of the enamel through acid production. Symptoms of tooth decay encompass toothache, sensitivity, discoloration, and the development of cavities. The impact of tooth decay extends beyond aesthetics, affecting the overall function and health of the teeth.
Conventional Polymerase Chain Reaction (PCR): Conventional PCR is a technique employed for the amplification and detection of specific DNA sequences of S. sputigena in subgingival plaque samples. Utilizing species-specific oligonucleotide primers, this method can selectively bind to the target DNA, generating multiple copies for visualization. PCR is known for its simplicity, specificity, and sensitivity, and it is capable of detecting even fewer than 10 S. sputigena cells.
Gene Activity Sequencing: Bacterial gene activity sequencing, utilizing next-generation sequencing (NGS) platforms, offers an in-depth analysis of gene expression in S. sputigena and other bacteria within plaque samples. This advanced technique generates millions of short reads of bacterial RNA transcripts, allowing for mapping to reference genomes. By annotating the reads, it becomes possible to identify genes and pathways involved in bacterial activity, unveiling hidden bacterial species and their functions behind tooth decay.
Microscopic Imaging: Microscopic imaging techniques, including light microscopy, fluorescence microscopy, or electron microscopy, directly observe the morphology and motility of S. sputigena and other bacteria in plaque samples. These imaging methods magnify bacterial cells and structures, providing visual insights into the bacterial characteristics within the oral environment.
Quantitative Polymerase Chain Reaction (qPCR): Quantitative PCR, a molecular technique with high specificity and sensitivity, is employed to detect and quantify S. sputigena DNA in subgingival plaque samples. Using species-specific oligonucleotide primers, qPCR enhances the rapid detection and enumeration of Selenomonas species.
Good oral hygiene practices prevent S. sputigena infections and associated conditions like periodontitis and caries. This includes brushing teeth twice daily, flossing daily, using mouthwash, and having regular dental check-ups. These practices aid in plaque and bacteria removal, preventing the formation of biofilms and cavities.
Smoking is a risk factor that can exacerbate periodontal disease and caries by impairing the immune system and blood flow to the gums. Quitting smoking creates a less favorable environment for anaerobic bacteria like S. sputigena.
Excessive sugar consumption provides a substrate for S. sputigena and other bacteria to produce acid, causing damage to tooth enamel and gums. Limiting sugar intake helps mitigate the risk of S. sputigena infection and its complications.
Using antimicrobial agents as adjunctive therapies to mechanical plaque removal can be effective. These agents, applied locally (toothpaste, gel, rinse, or spray) or systemically (tablets, capsules, or injections), can inhibit bacterial growth. Some effective antimicrobial agents include chlorhexidine, metronidazole, amoxicillin, and tetracycline. Dentist-prescribed and monitored use is essential to prevent adverse effects.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
